Advertisement
UK markets close in 8 hours 8 minutes
  • FTSE 100

    8,066.33
    +42.46 (+0.53%)
     
  • FTSE 250

    19,633.89
    +34.50 (+0.18%)
     
  • AIM

    750.00
    +0.82 (+0.11%)
     
  • GBP/EUR

    1.1579
    -0.0010 (-0.08%)
     
  • GBP/USD

    1.2347
    -0.0004 (-0.03%)
     
  • Bitcoin GBP

    53,755.20
    +134.85 (+0.25%)
     
  • CMC Crypto 200

    1,399.13
    -15.63 (-1.10%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    83.02
    +0.17 (+0.21%)
     
  • GOLD FUTURES

    2,317.60
    -28.80 (-1.23%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,800.18
    +288.49 (+1.75%)
     
  • DAX

    18,022.22
    +161.42 (+0.90%)
     
  • CAC 40

    8,079.86
    +39.50 (+0.49%)
     

Can Teva’s Debt Repayment Plan Deleverage Its Balance Sheet?

Can Teva’s Debt Repayment Plan Deleverage Its Balance Sheet?

Can Teva Pharmaceutical's Restructuring Plan Help It Recuperate? Teva Pharmaceutical Industries (TEVA) has a debt of $34 billion on its balance sheet. The company is focused on reducing its net debt obligations to optimum levels over the coming years.